Galena Biopharma licenses anti-nausea drug in U.S.

Galena Biopharma licenses anti-nausea drug in U.S.

The Portland-based biopharmaceutical company has licensed the U.S. rights for Zuplenz, an oral film that contains an anti-nausea medication, ondansetron.

There's a $1 billion market for the class of drugs to which the active ingredient belongs.

To take ondansetron, patients currently must swallow a pill and hold it down long enough to be digested, Galena President/CEO Mark Ahn said.

Read more at Portland Business Journal